RT Journal Article
SR Electronic
T1 Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003635
DO 10.1136/jitc-2021-003635
VO 10
IS 3
A1 Jiang, Haiping
A1 Yu, Xiongfei
A1 Li, Ning
A1 Kong, Mei
A1 Ma, Zhimin
A1 Zhou, Donghui
A1 Wang, Weibin
A1 Wang, Haohao
A1 Wang, Haiyong
A1 He, Kuifeng
A1 Li, Zhongqi
A1 Lu, Yimin
A1 Zhang, Jing
A1 Zhao, Kui
A1 Zhang, Yafei
A1 Xu, Nong
A1 Li, Ziran
A1 Liu, Ying
A1 Wang, Yan
A1 Wang, Yisen
A1 Teng, Lisong
YR 2022
UL http://jitc.bmj.com/content/10/3/e003635.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.